Headquartered in New Haven, CT,Achillion applies expertise in biology and structure-guided design and a deep understanding of patient and clinician needs to develop innovative treatment solutions aimed at improving the lives of patients. More...
Hepatitis C is a worldwide epidemic affecting more than 150 million individuals. Click to learn more about this disease.
Deutsche Bank 40th Annual Health Care Conference
Achillion Presents Detailed Clinical Results on ACH-3102 and ACH-3422 at the International Liver Congress
Achillion Announces Upcoming Presentations at the International Liver Congress 2015 (EASL)